+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Performance and Financial Assessment of the Global Contract Research Organisation Industry

  • ID: 3276563
  • Report
  • June 2015
  • Region: Global
  • 59 Pages
  • Frost & Sullivan
Financial Management is the Key Strategy for Sustainability.


  • Covance Inc.
  • PRA Health Sciences, Inc.
  • MORE
This industry performance and financial assessment of the global contract research organization (CRO) industry analyzes the financial ratios of companies across the globe. The research objectives are to rank companies based on their financial and risk management and identify key trends that can impact the performance of the industry participants over the next year. To assess the financial performance, ratios are divided into 4 categories: profitability, liquidity, activity (turnover), and solvency. Top performers in each industry are also highlighted.

Key Issues/Challenges that Impact the Contract Research Organization (CRO) Industry:

- Lower pharmaceutical and biotechnology company profitability.
- Patent expiry and revenue loss in pharma and biotech companies.
- Declining research and development (R&D) by large pharma companies.

Key Findings:

- The increasing cost of drug production, sales, and marketing have dented the past high profit margin of top pharmaceutical participants.
- All margin parameters remained relatively constant during the study period, indicating stability.
- Except for return on capital employed, all other ratios witnessed stable growth. The return on capital employed varied.
- The industry has tried to improve accounts receivable, which becomes the key when pharmaceutical R&D is haunted by uncertainties and challenges in bringing a drug from laboratory to market.

Note: Product cover images may vary from those shown


  • Covance Inc.
  • PRA Health Sciences, Inc.
  • MORE
1. Executive Summary

Executive Summary

2. Key Terms Used in the Study

Key Terms Used in the Study

3. Introduction

Research Methodology
Research Objectives and Scope
Ratios Used for Analysis
Companies Included in the Study

4. Key Trends that impact the CRO Industry

Key Trends That Impact the CRO Industry
Declining Profitability
Patent Expiry and Revenue Loss for Pharma and Biotech Industry
Pharma and Biotech Industry - Declining R&D

5. The CRO Industry

The CRO Industry
CRO Industry Value Chain
CRO Industry Business Model

6. Financial Assessment

Financial Assessment
CRO Industry - Margin Analysis
CRO Industry - Profitability Analysis
CRO Industry - Turnover Analysis
CRO Industry - Cash Reserve Analysis

7. Financial Benchmarking

Financial Benchmarking
CRO Industry - Profitability Ranking
CRO Industry - Activity Ranking
CRO Industry - Liquidity Ranking
CRO Industry - Solvency Ranking
CRO Industry - Overall Financial and Risk Management Ranking

8. Key Participant Profiles

Key Participant Profiles
Company Profile - ICON Public Limited Company
Company Profile - Charles River Laboratories International, Inc.
Company Profile - Covance Inc.
Company Profile - INC Research Holdings, Inc.
Company Profile - inVentiv Health Clinical, Inc.
Company Profile - PAREXEL International Corporation
Company Profile - Pharmaceutical Product Development
Company Profile - PRA Health Sciences, Inc.
Company Profile - Quintiles Transnational Holdings Inc.
Company Profile - WuXi PharmaTech (Cayman) Inc.

9. Conclusions

Legal Disclaimer
Note: Product cover images may vary from those shown
- Charles River Laboratories International, Inc.
- Covance Inc.
- ICON Public Limited Company
- INC Research Holdings, Inc.
- PAREXEL International Corporation
- PRA Health Sciences, Inc.
- Pharmaceutical Product Development
- Quintiles Transnational Holdings Inc.
- WuXi PharmaTech (Cayman) Inc.
- inVentiv Health Clinical, Inc.
Note: Product cover images may vary from those shown